nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.43	0.571	CbGbCtD
Quinidine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.223	0.296	CbGbCtD
Quinidine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0997	0.132	CbGbCtD
Quinidine—SCN3A—spinal nerve—amyotrophic lateral sclerosis	0.0126	0.186	CbGeAlD
Quinidine—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.00679	0.0532	CcSEcCtD
Quinidine—Quinidine barbiturate—GRIA2—amyotrophic lateral sclerosis	0.00634	1	CrCbGaD
Quinidine—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.00517	0.0405	CcSEcCtD
Quinidine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0323	CcSEcCtD
Quinidine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0302	CcSEcCtD
Quinidine—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0248	CcSEcCtD
Quinidine—KCNK1—hindbrain—amyotrophic lateral sclerosis	0.00303	0.0448	CbGeAlD
Quinidine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0231	CcSEcCtD
Quinidine—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00268	0.021	CcSEcCtD
Quinidine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00268	0.021	CcSEcCtD
Quinidine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.019	CcSEcCtD
Quinidine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0188	CcSEcCtD
Quinidine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0178	CcSEcCtD
Quinidine—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0178	CcSEcCtD
Quinidine—SCN1A—hindbrain—amyotrophic lateral sclerosis	0.00225	0.0332	CbGeAlD
Quinidine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0173	CcSEcCtD
Quinidine—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0172	CcSEcCtD
Quinidine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0169	CcSEcCtD
Quinidine—SCN2A—hindbrain—amyotrophic lateral sclerosis	0.00206	0.0305	CbGeAlD
Quinidine—KCNK6—nervous system—amyotrophic lateral sclerosis	0.00205	0.0303	CbGeAlD
Quinidine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.002	0.0157	CcSEcCtD
Quinidine—KCNK6—central nervous system—amyotrophic lateral sclerosis	0.00197	0.0292	CbGeAlD
Quinidine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0154	CcSEcCtD
Quinidine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0153	CcSEcCtD
Quinidine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0146	CcSEcCtD
Quinidine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0143	CcSEcCtD
Quinidine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0138	CcSEcCtD
Quinidine—KCNK1—brainstem—amyotrophic lateral sclerosis	0.00173	0.0257	CbGeAlD
Quinidine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0131	CcSEcCtD
Quinidine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00165	0.013	CcSEcCtD
Quinidine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0127	CcSEcCtD
Quinidine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0126	CcSEcCtD
Quinidine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0125	CcSEcCtD
Quinidine—KCNK6—brain—amyotrophic lateral sclerosis	0.00157	0.0232	CbGeAlD
Quinidine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0122	CcSEcCtD
Quinidine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0119	CcSEcCtD
Quinidine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0116	CcSEcCtD
Quinidine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0113	CcSEcCtD
Quinidine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0111	CcSEcCtD
Quinidine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0109	CcSEcCtD
Quinidine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0104	CcSEcCtD
Quinidine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0102	CcSEcCtD
Quinidine—SCN1A—brainstem—amyotrophic lateral sclerosis	0.00129	0.019	CbGeAlD
Quinidine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00991	CcSEcCtD
Quinidine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00971	CcSEcCtD
Quinidine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00958	CcSEcCtD
Quinidine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00953	CcSEcCtD
Quinidine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00953	CcSEcCtD
Quinidine—KCNK1—medulla oblongata—amyotrophic lateral sclerosis	0.00121	0.0179	CbGeAlD
Quinidine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00942	CcSEcCtD
Quinidine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00935	CcSEcCtD
Quinidine—SCN2A—brainstem—amyotrophic lateral sclerosis	0.00118	0.0175	CbGeAlD
Quinidine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00901	CcSEcCtD
Quinidine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00891	CcSEcCtD
Quinidine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00885	CcSEcCtD
Quinidine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00861	CcSEcCtD
Quinidine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00859	CcSEcCtD
Quinidine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00855	CcSEcCtD
Quinidine—KCNK1—spinal cord—amyotrophic lateral sclerosis	0.00108	0.016	CbGeAlD
Quinidine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00835	CcSEcCtD
Quinidine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0083	CcSEcCtD
Quinidine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000993	0.00778	CcSEcCtD
Quinidine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000974	0.00763	CcSEcCtD
Quinidine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000968	0.00758	CcSEcCtD
Quinidine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00746	CcSEcCtD
Quinidine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00095	0.00744	CcSEcCtD
Quinidine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000949	0.00743	CcSEcCtD
Quinidine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000936	0.00733	CcSEcCtD
Quinidine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000931	0.00729	CcSEcCtD
Quinidine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000918	0.00719	CcSEcCtD
Quinidine—KCNK1—nervous system—amyotrophic lateral sclerosis	0.000908	0.0134	CbGeAlD
Quinidine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000902	0.00707	CcSEcCtD
Quinidine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000902	0.00707	CcSEcCtD
Quinidine—SCN1A—medulla oblongata—amyotrophic lateral sclerosis	0.000898	0.0133	CbGeAlD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000896	0.00702	CcSEcCtD
Quinidine—KCNK1—central nervous system—amyotrophic lateral sclerosis	0.000875	0.0129	CbGeAlD
Quinidine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00683	CcSEcCtD
Quinidine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000865	0.00677	CcSEcCtD
Quinidine—KCNK1—cerebellum—amyotrophic lateral sclerosis	0.000855	0.0126	CbGeAlD
Quinidine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000851	0.00666	CcSEcCtD
Quinidine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000848	0.00664	CcSEcCtD
Quinidine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000847	0.00663	CcSEcCtD
Quinidine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000844	0.00661	CcSEcCtD
Quinidine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00084	0.00658	CcSEcCtD
Quinidine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00655	CcSEcCtD
Quinidine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000824	0.00646	CcSEcCtD
Quinidine—SCN2A—medulla oblongata—amyotrophic lateral sclerosis	0.000824	0.0122	CbGeAlD
Quinidine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000808	0.00633	CcSEcCtD
Quinidine—SCN1A—spinal cord—amyotrophic lateral sclerosis	0.000801	0.0118	CbGeAlD
Quinidine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000788	0.00617	CcSEcCtD
Quinidine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000771	0.00604	CcSEcCtD
Quinidine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000752	0.00589	CcSEcCtD
Quinidine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000747	0.00585	CcSEcCtD
Quinidine—SCN2A—spinal cord—amyotrophic lateral sclerosis	0.000735	0.0109	CbGeAlD
Quinidine—SCN3A—medulla oblongata—amyotrophic lateral sclerosis	0.000724	0.0107	CbGeAlD
Quinidine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000713	0.00558	CcSEcCtD
Quinidine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000707	0.00554	CcSEcCtD
Quinidine—KCNK1—brain—amyotrophic lateral sclerosis	0.000694	0.0103	CbGeAlD
Quinidine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00538	CcSEcCtD
Quinidine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000684	0.00535	CcSEcCtD
Quinidine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000684	0.00535	CcSEcCtD
Quinidine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000678	0.01	CbGeAlD
Quinidine—SCN1A—nervous system—amyotrophic lateral sclerosis	0.000675	0.00998	CbGeAlD
Quinidine—SCN1A—central nervous system—amyotrophic lateral sclerosis	0.000649	0.00961	CbGeAlD
Quinidine—SCN3A—spinal cord—amyotrophic lateral sclerosis	0.000646	0.00955	CbGeAlD
Quinidine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000637	0.00499	CcSEcCtD
Quinidine—SCN1A—cerebellum—amyotrophic lateral sclerosis	0.000635	0.00939	CbGeAlD
Quinidine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00062	0.00486	CcSEcCtD
Quinidine—SCN2A—nervous system—amyotrophic lateral sclerosis	0.000619	0.00916	CbGeAlD
Quinidine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000612	0.00479	CcSEcCtD
Quinidine—SCN2A—central nervous system—amyotrophic lateral sclerosis	0.000596	0.00882	CbGeAlD
Quinidine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000592	0.00463	CcSEcCtD
Quinidine—ORM1—spinal cord—amyotrophic lateral sclerosis	0.000588	0.0087	CbGeAlD
Quinidine—SCN2A—cerebellum—amyotrophic lateral sclerosis	0.000583	0.00862	CbGeAlD
Quinidine—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.000581	0.0086	CbGeAlD
Quinidine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000572	0.00448	CcSEcCtD
Quinidine—SLC22A4—spinal cord—amyotrophic lateral sclerosis	0.000565	0.00837	CbGeAlD
Quinidine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00055	0.00431	CcSEcCtD
Quinidine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00427	CcSEcCtD
Quinidine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00427	CcSEcCtD
Quinidine—SCN3A—nervous system—amyotrophic lateral sclerosis	0.000544	0.00805	CbGeAlD
Quinidine—SCN5A—nervous system—amyotrophic lateral sclerosis	0.000543	0.00803	CbGeAlD
Quinidine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000542	0.00424	CcSEcCtD
Quinidine—SCN3A—central nervous system—amyotrophic lateral sclerosis	0.000524	0.00775	CbGeAlD
Quinidine—SCN5A—central nervous system—amyotrophic lateral sclerosis	0.000522	0.00773	CbGeAlD
Quinidine—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.000519	0.00767	CbGeAlD
Quinidine—SCN1A—brain—amyotrophic lateral sclerosis	0.000516	0.00763	CbGeAlD
Quinidine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000514	0.00402	CcSEcCtD
Quinidine—SCN3A—cerebellum—amyotrophic lateral sclerosis	0.000512	0.00758	CbGeAlD
Quinidine—ORM1—nervous system—amyotrophic lateral sclerosis	0.000495	0.00733	CbGeAlD
Quinidine—ORM1—central nervous system—amyotrophic lateral sclerosis	0.000477	0.00706	CbGeAlD
Quinidine—SCN2A—brain—amyotrophic lateral sclerosis	0.000473	0.007	CbGeAlD
Quinidine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.000462	0.00683	CbGeAlD
Quinidine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000454	0.00671	CbGeAlD
Quinidine—SLC22A4—cerebellum—amyotrophic lateral sclerosis	0.000448	0.00663	CbGeAlD
Quinidine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.000445	0.00658	CbGeAlD
Quinidine—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.000444	0.00657	CbGeAlD
Quinidine—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.000437	0.00646	CbGeAlD
Quinidine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000437	0.00646	CbGeAlD
Quinidine—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.000421	0.00622	CbGeAlD
Quinidine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00042	0.00621	CbGeAlD
Quinidine—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.000417	0.00617	CbGeAlD
Quinidine—SCN3A—brain—amyotrophic lateral sclerosis	0.000416	0.00615	CbGeAlD
Quinidine—SCN5A—brain—amyotrophic lateral sclerosis	0.000415	0.00614	CbGeAlD
Quinidine—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.000411	0.00608	CbGeAlD
Quinidine—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.000402	0.00594	CbGeAlD
Quinidine—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000396	0.00586	CbGeAlD
Quinidine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000388	0.00575	CbGeAlD
Quinidine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.000374	0.00554	CbGeAlD
Quinidine—SLC22A4—brain—amyotrophic lateral sclerosis	0.000364	0.00539	CbGeAlD
Quinidine—CHRM2—brain—amyotrophic lateral sclerosis	0.000353	0.00522	CbGeAlD
Quinidine—SLC22A1—brain—amyotrophic lateral sclerosis	0.000347	0.00513	CbGeAlD
Quinidine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000342	0.00506	CbGeAlD
Quinidine—SLCO1A2—brain—amyotrophic lateral sclerosis	0.000334	0.00494	CbGeAlD
Quinidine—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000334	0.00494	CbGeAlD
Quinidine—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000321	0.00475	CbGeAlD
Quinidine—SLC22A8—brain—amyotrophic lateral sclerosis	0.000319	0.00472	CbGeAlD
Quinidine—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000314	0.00464	CbGeAlD
Quinidine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000305	0.00451	CbGeAlD
Quinidine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000305	0.00451	CbGeAlD
Quinidine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.000297	0.00439	CbGeAlD
Quinidine—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000282	0.00417	CbGeAlD
Quinidine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000274	0.00405	CbGeAlD
Quinidine—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000271	0.00401	CbGeAlD
Quinidine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000264	0.0039	CbGeAlD
Quinidine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000257	0.0038	CbGeAlD
Quinidine—KCNH2—brain—amyotrophic lateral sclerosis	0.000255	0.00377	CbGeAlD
Quinidine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000247	0.00366	CbGeAlD
Quinidine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000242	0.00358	CbGeAlD
Quinidine—SLC22A5—brain—amyotrophic lateral sclerosis	0.000241	0.00357	CbGeAlD
Quinidine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000233	0.00345	CbGeAlD
Quinidine—CYP1A1—brain—amyotrophic lateral sclerosis	0.000215	0.00319	CbGeAlD
Quinidine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000209	0.0031	CbGeAlD
Quinidine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000207	0.00306	CbGeAlD
Quinidine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000203	0.00301	CbGeAlD
Quinidine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000199	0.00294	CbGeAlD
Quinidine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000196	0.00291	CbGeAlD
Quinidine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000196	0.0029	CbGeAlD
Quinidine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000195	0.00288	CbGeAlD
Quinidine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000191	0.00283	CbGeAlD
Quinidine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000174	0.00257	CbGeAlD
Quinidine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000156	0.0023	CbGeAlD
Quinidine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000146	0.00217	CbGeAlD
Quinidine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000141	0.00208	CbGeAlD
Quinidine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000138	0.00204	CbGeAlD
Quinidine—ABCB1—brain—amyotrophic lateral sclerosis	0.000112	0.00165	CbGeAlD
Quinidine—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.46e-05	0.000766	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.44e-05	0.000762	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.44e-05	0.000762	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.42e-05	0.000757	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.37e-05	0.000746	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.37e-05	0.000746	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	3.37e-05	0.000745	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.36e-05	0.000744	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.27e-05	0.000724	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.27e-05	0.000724	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.25e-05	0.000719	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.18e-05	0.000703	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.18e-05	0.000703	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.15e-05	0.000697	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.13e-05	0.000693	CbGpPWpGaD
Quinidine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.12e-05	0.000691	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.1e-05	0.000686	CbGpPWpGaD
Quinidine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.1e-05	0.000685	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.09e-05	0.000682	CbGpPWpGaD
Quinidine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.08e-05	0.000681	CbGpPWpGaD
Quinidine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.05e-05	0.000676	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.01e-05	0.000666	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3e-05	0.000664	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.97e-05	0.000657	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.97e-05	0.000656	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CHAT—amyotrophic lateral sclerosis	2.95e-05	0.000653	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.93e-05	0.000649	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.93e-05	0.000648	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.92e-05	0.000646	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.92e-05	0.000645	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.92e-05	0.000645	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.91e-05	0.000644	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.91e-05	0.000643	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.89e-05	0.00064	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.87e-05	0.000634	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.8e-05	0.00062	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.79e-05	0.000617	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.78e-05	0.000615	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.75e-05	0.000609	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—MMP9—amyotrophic lateral sclerosis	2.75e-05	0.000608	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.73e-05	0.000604	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.72e-05	0.000601	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.7e-05	0.000598	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.7e-05	0.000598	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.7e-05	0.000596	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.69e-05	0.000596	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	2.69e-05	0.000595	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.67e-05	0.00059	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.65e-05	0.000586	CbGpPWpGaD
Quinidine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.65e-05	0.000585	CbGpPWpGaD
Quinidine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.61e-05	0.000577	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.6e-05	0.000576	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.6e-05	0.000574	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.57e-05	0.000568	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.57e-05	0.000567	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	2.55e-05	0.000564	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.55e-05	0.000563	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.54e-05	0.000562	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.54e-05	0.000562	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.54e-05	0.000562	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.52e-05	0.000558	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.5e-05	0.000554	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.5e-05	0.000552	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.49e-05	0.000551	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.48e-05	0.000548	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.47e-05	0.000546	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.46e-05	0.000545	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	2.44e-05	0.000539	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.39e-05	0.000529	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.39e-05	0.000529	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.37e-05	0.000525	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.37e-05	0.000525	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.37e-05	0.000525	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	2.35e-05	0.000521	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.35e-05	0.00052	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.34e-05	0.000517	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.33e-05	0.000516	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.33e-05	0.000515	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.32e-05	0.000514	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.3e-05	0.000509	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.28e-05	0.000505	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.25e-05	0.000498	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.25e-05	0.000498	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.25e-05	0.000497	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.21e-05	0.000489	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.19e-05	0.000485	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.19e-05	0.000484	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.17e-05	0.00048	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.16e-05	0.000478	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.11e-05	0.000466	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.11e-05	0.000466	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.04e-05	0.000452	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.04e-05	0.00045	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.03e-05	0.000449	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.03e-05	0.000449	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.03e-05	0.000449	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.02e-05	0.000446	CbGpPWpGaD
Quinidine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.01e-05	0.000446	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.01e-05	0.000444	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.98e-05	0.000438	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.96e-05	0.000434	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	1.93e-05	0.000428	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.93e-05	0.000427	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.92e-05	0.000425	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.91e-05	0.000423	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.9e-05	0.000421	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.9e-05	0.00042	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.89e-05	0.000418	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.89e-05	0.000417	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.85e-05	0.00041	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.85e-05	0.000409	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.85e-05	0.000408	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.84e-05	0.000406	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.82e-05	0.000402	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.8e-05	0.000398	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.76e-05	0.000389	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.74e-05	0.000385	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.74e-05	0.000385	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.73e-05	0.000383	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.72e-05	0.000381	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.72e-05	0.000379	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.71e-05	0.000378	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.71e-05	0.000377	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.62e-05	0.000359	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.62e-05	0.000358	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.61e-05	0.000356	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.6e-05	0.000353	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.59e-05	0.000351	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.58e-05	0.000349	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.57e-05	0.000347	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.57e-05	0.000346	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.57e-05	0.000346	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.54e-05	0.000341	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.47e-05	0.000326	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.47e-05	0.000324	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.47e-05	0.000324	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	0.000324	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	0.000322	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.43e-05	0.000317	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.43e-05	0.000316	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.4e-05	0.00031	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.39e-05	0.000308	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.39e-05	0.000308	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.38e-05	0.000304	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000297	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.33e-05	0.000294	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.32e-05	0.000293	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.32e-05	0.000292	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.32e-05	0.000291	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.31e-05	0.00029	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.3e-05	0.000288	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.28e-05	0.000284	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.25e-05	0.000277	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.24e-05	0.000275	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000269	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.21e-05	0.000268	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.21e-05	0.000268	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.21e-05	0.000267	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.2e-05	0.000265	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	1.2e-05	0.000265	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000255	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	0.00025	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.13e-05	0.00025	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.12e-05	0.000248	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.11e-05	0.000246	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000244	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000242	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.05e-05	0.000233	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.00023	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.04e-05	0.00023	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.04e-05	0.00023	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.03e-05	0.000227	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.02e-05	0.000225	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1e-05	0.000221	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	9.94e-06	0.00022	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	9.85e-06	0.000218	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.67e-06	0.000214	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.55e-06	0.000211	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.54e-06	0.000211	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.46e-06	0.000209	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	9.4e-06	0.000208	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.34e-06	0.000207	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.99e-06	0.000199	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.89e-06	0.000197	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.87e-06	0.000196	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.58e-06	0.00019	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	8.56e-06	0.000189	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.45e-06	0.000187	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.42e-06	0.000186	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.26e-06	0.000183	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.22e-06	0.000182	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.91e-06	0.000175	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	7.86e-06	0.000174	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	7.85e-06	0.000174	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.69e-06	0.00017	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.68e-06	0.00017	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.57e-06	0.000167	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.53e-06	0.000167	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.31e-06	0.000162	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.23e-06	0.00016	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.1e-06	0.000157	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.06e-06	0.000156	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.92e-06	0.000153	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.86e-06	0.000152	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.8e-06	0.00015	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.52e-06	0.000144	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.51e-06	0.000144	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.5e-06	0.000144	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.16e-06	0.000136	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.01e-06	0.000133	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.98e-06	0.000132	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.87e-06	0.00013	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	5.81e-06	0.000129	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	5.69e-06	0.000126	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.67e-06	0.000125	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.59e-06	0.000124	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.38e-06	0.000119	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.38e-06	0.000119	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.37e-06	0.000119	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.34e-06	0.000118	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.3e-06	0.000117	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.26e-06	0.000116	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.21e-06	0.000115	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.01e-06	0.000111	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4.92e-06	0.000109	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.91e-06	0.000109	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.87e-06	0.000108	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.62e-06	0.000102	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.53e-06	0.0001	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.29e-06	9.48e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.16e-06	9.2e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.04e-06	8.93e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4e-06	8.86e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.98e-06	8.81e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.9e-06	8.63e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.68e-06	8.13e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.56e-06	7.87e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.49e-06	7.73e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.42e-06	7.57e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.37e-06	7.46e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.36e-06	7.44e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.21e-06	7.1e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.02e-06	6.68e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.94e-06	6.5e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.77e-06	6.12e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.74e-06	6.07e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.64e-06	5.84e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.34e-06	5.19e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.28e-06	5.05e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.81e-06	4e-05	CbGpPWpGaD
